Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$6.52 - $8.95 $326,000 - $447,499
50,000 New
50,000 $375,000
Q1 2020

May 15, 2020

SELL
$3.53 - $12.21 $191,117 - $661,061
-54,141 Reduced 27.68%
141,442 $587,000
Q4 2019

Feb 14, 2020

BUY
$11.58 - $17.37 $2.26 Million - $3.4 Million
195,583 New
195,583 $2.38 Million
Q2 2018

Aug 14, 2018

SELL
$6.85 - $38.49 $702,426 - $3.95 Million
-102,544 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$8.34 - $12.5 $855,216 - $1.28 Million
102,544 New
102,544 $0

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.